Form 4: Rafael Holdings Chief Medical Officer, John Goldberg, Acquires 50,000 Shares of Class B Common Stock

John Goldberg, Chief Medical Officer of Rafael Holdings, Inc., acquired 50,000 shares of Class B Common Stock on January 13, 2025, at a price of $1.954 per share.

Summary

• On January 13, 2025, John Goldberg, the Chief Medical Officer of Rafael Holdings, Inc., acquired 50,000 shares of Class B Common Stock.
• The acquisition price was $1.954 per share.
• These shares are restricted stock and will vest in four equal installments of 12,500 shares on January 13 of 2026, 2027, 2028, and 2029.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by an executive. The vesting schedule suggests a long-term commitment, which is mildly positive.

Positives

• The acquisition of shares by a key executive could be seen as a positive signal about the executive's confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure related to insider trading. It's common for executives to receive stock as part of their compensation, and these transactions are closely monitored by regulators and investors.

Comparison to Industry Standards

• Stock grants to executives are a common practice across the pharmaceutical and biotechnology industries.
• Vesting schedules, like the four-year schedule described in the document, are also standard.
• Comparing the size of this grant to similar companies would require analyzing executive compensation packages in the peer group.

Stakeholder Impact

• The acquisition of shares by the Chief Medical Officer could increase investor confidence.

Key Dates